Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival and Health Care Burden of Children With Retinoblastoma in Europe.
Virgili G, Capocaccia R, Botta L, Bennett D, Hadjistilianou T, Innos K, Karim-Kos H, Kuehni CE, Kuhnel U, Mazzini C, Canete Nieto A, Paapsi K, Parravano M, Ronckers CM, Rossi S, Stiller C, Vicini G, Visser O, Gatta G; EUROCARE-6 Working Group. Virgili G, et al. Among authors: visser o. JAMA Ophthalmol. 2024 Oct 10;142(11):1062-70. doi: 10.1001/jamaophthalmol.2024.4140. Online ahead of print. JAMA Ophthalmol. 2024. PMID: 39388193
Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome.
Huls G, Chitu DA, Tick L, Boersma R, Breems D, Herbers A, Klein SK, de Jonge S, Westerweel PE, Cruijsen M, Hoogendoorn M, Cuijpers M, Deeren D, Bailly B, Visser O, van Rhenen A, Posthuma EFM, Valk PJM, Cloos J, Ammatuna E, Refos JM, Fakkert R, Löwenberg B, Ossenkoppele GJ. Huls G, et al. Among authors: visser o. Ann Hematol. 2024 Oct 5. doi: 10.1007/s00277-024-06033-y. Online ahead of print. Ann Hematol. 2024. PMID: 39367118
Risk Stratification in Older Intensively Treated Patients With AML.
Versluis J, Metzner M, Wang A, Gradowska P, Thomas A, Jakobsen NA, Kennedy A, Moore R, Boertjes E, Vonk CM, Kavelaars FG, Rijken M, Gilkes A, Schwab C, Beverloo HB, Manz M, Visser O, Van Elssen CHMJ, de Weerdt O, Tick LW, Biemond BJ, Vekemans MC, Freeman SD, Harrison CJ, Cook JA, Dennis M, Knapper S, Thomas I, Craddock C, Ossenkoppele GJ, Löwenberg B, Russell N, Valk PJM, Vyas P. Versluis J, et al. Among authors: visser o. J Clin Oncol. 2024 Sep 4:JCO2302631. doi: 10.1200/JCO.23.02631. Online ahead of print. J Clin Oncol. 2024. PMID: 39231389
Facing further challenges in cancer data quality and harmonisation.
Giusti F, Martos C, Carvalho RN, Zadnik V, Visser O, Bettio M, Van Eycken L. Giusti F, et al. Among authors: visser o. Front Oncol. 2024 Jul 25;14:1438805. doi: 10.3389/fonc.2024.1438805. eCollection 2024. Front Oncol. 2024. PMID: 39119089 Free PMC article.
Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity.
de Jonge NA, Janssen JJWM, Ypma P, Herbers AHE, de Kreuk A, Vasmel W, van den Ouweland JMW, Beeker A, Visser O, Zweegman S, Blijlevens NMA, van Agtmael MA, Sikkens JJ. de Jonge NA, et al. Among authors: visser o. Support Care Cancer. 2024 Aug 8;32(9):579. doi: 10.1007/s00520-024-08776-w. Support Care Cancer. 2024. PMID: 39115709 Free PMC article.
Response to DA-EPOCH-R is associated with activation of 'fitter' cytotoxic T cells in patients with newly diagnosed double and triple hit high-grade B-cell lymphoma.
De Jonge AV, Bruins WSC, Duetz C, Korst CLBM, Rentenaar R, Cosovic M, Eken M, Kersten MJ, Sandberg Y, Van Rijn RS, Fijnheer R, Mutsaers P, Vergote VKJ, Issa D, Beeker A, Bilgin YM, Visser O, Van Werkhoven E, Roemer MGM, Chamuleau MED, Mutis T. De Jonge AV, et al. Among authors: visser o. Haematologica. 2024 Nov 1;109(11):3760-3765. doi: 10.3324/haematol.2024.285170. Haematologica. 2024. PMID: 38961740 Free PMC article. No abstract available.
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry.
Brink M, Huisman F, Meeuwes FO, van der Poel MWM, Kersten MJ, Wondergem M, Böhmer L, Woei-A-Jin FJSH, Visser O, Oostvogels R, Jansen PM, Diepstra A, Snijders TJF, Huls G, Vermaat JSP, Plattel WJ, Nijland M. Brink M, et al. Among authors: visser o. Blood Adv. 2024 Jul 23;8(14):3619-3628. doi: 10.1182/bloodadvances.2023012531. Blood Adv. 2024. PMID: 38739705 Free PMC article.
372 results